New Developments in Myocardial Ischemia Research
Heart failure caused by atherosclerosis-associated myocardial ischemia is a major cause of morbidity and mortality in developed countries in spite of great progress in intervention and medications. Beta-blockers, angiotensin-converting enzyme (ACE), ventricular resynchronization therapy (biventricular pacing) and ventricular assist devices cannot fully prevent this disease. The research on possible alternative therapies, as well as novel strategies for non-invasive assessment of myocardial ischemia, continues actively in the 21st century and offers novel opportunities, some already in use through clinical practice.
This book offers topics related to diagnosis and therapy of myocardial ischemia for a wide range of researchers in both academia and in the clinical field, for both undergraduate and graduate level students. Studies ranging from stem cell-based therapies to new promising biomarkers associated with coronary artery disease are discussed in depth. Non-invasive assessment of myocardial perfusion (Cardiac Magnetic Resonance), as well as diagnostic and prognostic role of cardiopulmonary stress test, are also covered. Leading experts give educated insight on myocardial ischemia in each chapter.
The book is the result of collaborative efforts from all Members of The Italian working group on Atherosclerosis of The Italian Society of Cardiology and different investigators in the research field of myocardial ischemia around the world. The book is published on behalf of The Working Group on Atherosclerosis of The Italian Society of Cardiology.
It is envisioned that this book, with its proposition of diagnostic and therapeutic strategies for myocardial ischemia, will inspire a wide range of researchers and physicians towards new explorations and applications in the field of ischemic heart disease.